Fisiopatología e Investigación Clínica de las Enfermedades de Base Inmunológica e Inflamatoria Crónicas

Pena-Chilet, M; Blanquer-Maceiras, M; Ibarrola-Villava, M; Martinez-Cadenas, C; Martin-Gonzalez, M; Gomez-Fernandez, C; Mayor, M; Aviles, JA; Lluch, A; Ribas, G.

Genetic variants in PARP1 (rs3219090) and IRF4 (rs12203592) genes; associated with melanoma susceptibility in a Spanish population

BMC CANCER. 2013; 13: Nº de citas: 31 [doi:10.1186/1471-2407-13-160]

Aviles-Izquierdo, JA; Lazaro-Ochaita, P; Suarez-Fernandez, R; Marquez-Rodas, I; Parra-Blanco, V; Escat-Cortes, JL.

Epidemiological changes in cutaneous melanoma: retrospective study of 969 cases (1996-2010)

REVISTA CLINICA ESPANOLA. 2013; 213(2): 81-87 Nº de citas: 9 [doi:10.1016/j.rce.2012.06.006]

Sanchez-Ramon, S; Eguiluz-Gracia, I; Rodriguez-Mazariego, ME; Paravisini, A; Zubeldia-Ortuno, JM; Gil-Herrera, J; Fernandez-Cruz, E; Suarez-Fernandez, R.

Sequential Combined Therapy With Omalizumab and Rituximab: A New Approach to Severe Atopic Dermatitis

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2013; 23(3): 190-196 Nº de citas: 38

Aristimuno, C; Teijeiro, R; Valor, L; Alonso, B; Tejera-Alhambra, M; de Andres, C; Minarro, DO; Lopez-Lazareno, N; Faure, F; Sanchez-Ramon, S.

Sex-hormone receptors pattern on regulatory T-cells: clinical implications for multiple sclerosis

CLIN EXP MED. 2012; 12(4): 247-255 Nº de citas: 36 [doi:10.1007/s10238-011-0172-3]

Valor, L; Sarmiento, E; Navarro, J; Gallego, A; Fernandez-Yanez, J; Fernandez-Cruz, E; Carbone, J.

Evaluation of Lymphoproliferative Responses by Carboxy Fluorescein Succinimidyl Ester Assay in Heart Recipients With Infections

TRANSPLANTATION PROCEEDINGS. 2012; 44(9): 2649-2652 Nº de citas: 4 [doi:10.1016/j.transproceed.2012.09.054]

Sarmiento, E; del Pozo, N; Gallego, A; Fernandez-Yanez, J; Palomo, J; Villa, A; Ruiz, M; Munoz, P; Rodriguez, C; Rodriguez-Molina, J; Navarro, J; Kotsch, K; Fernandez-Cruz, E; Carbone, J.

Decreased levels of serum complement C3 and natural killer cells add to the predictive value of total immunoglobulin G for severe infection in heart transplant recipients

TRANSPLANT INFECTIOUS DISEASE. 2012; 14(5): 526-539 Nº de citas: 23 [doi:10.1111/j.1399-3062.2012.00757.x]

Ibarrola-Villava, M; Hu, HH; Guedj, M; Fernandez, LP; Descamps, V; Basset-Seguin, N; Bagot, M; Benssussan, A; Saiag, P; Fargnoli, MC; Peris, K; Aviles, JA; Lluch, A; Ribas, G; Soufir, N.

MC1R, SLC45A2 and TYR genetic variants involved in melanoma; susceptibility in Southern European populations: Results from a; Meta-analysis

EUROPEAN JOURNAL OF CANCER. 2012; 48(14): 2183-2191 Nº de citas: 34 [doi:10.1016/j.ejca.2012.03.006]

Calvino, E; Pajuelo, L; Manjon, JL; Sancho, P; Tejedor, MC; Gil, J; Fernandez-Cruz, E; Diez, JC.

Active fraction from Ganoderma lucidum with apoptosis activity on peripheral blood mononuclear cells from chronic lymphocytic leukemia

European Journal of Integrative Medicine. 2012; 4(3): 335-343 Nº de citas: 3 [doi:10.1016/j.eujim.2012.01.010]

Carbone, J; Lanio, N; Gallego, A; Kern, F; Navarro, J; Munoz, P; Alonso, R; Catalan, P; Fernandez-Yanez, J; Palomo, J; Ruiz, M; Fernandez-Cruz, E; Sarmiento, E.

Simultaneous Monitoring of Cytomegalovirus-Specific Antibody and T-cell levels in Seropositive Heart Transplant Recipients

JOURNAL OF CLINICAL IMMUNOLOGY. 2012; 32(4): 809-819 Nº de citas: 15 [doi:10.1007/s10875-012-9670-7]

Moraru, M; Carbone, J; Alecsandru, D; Castillo-Rama, M; Garcia-Segovia, A; Gil, J; Alonso, B; Aguaron, A; Ramos-Medina, R; de Maria, JM; Oliver-Minarro, D; Rodriguez-Mahou, M; Ortega, V; Caballero, P; Melia, E; Vidal, J; Cianchetta-Sivori, M; Esteban, C; Vargas-Henny, L; Dale, J; Ortiz-Quintana, L; Fernandez-Cruz, E; Sanchez-Ramon, S.

Intravenous Immunoglobulin Treatment Increased Live Birth Rate in a Spanish Cohort of Women with Recurrent Reproductive Failure and Expanded CD56+ Cells

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2012; 68(1): 75-84 Nº de citas: 92 [doi:10.1111/j.1600-0897.2012.01135.x]

Ramos-Medina, R; Corbi, AL; Sanchez-Ramon, S.

Intravenous immunoglobulin: immunomodulatory key of the immune system

MEDICINA CLINICA. 2012; 139(3): 112-117 Nº de citas: 10 [doi:10.1016/j.medcli.2011.11.022]

Tejera-Alhambra, M; Alonso, B; Teijeiro, R; Ramos-Medina, R; Aristimuno, C; Valor, L; de Andres, C; Sanchez-Ramon, S.

Perforin Expression by CD4+ Regulatory T Cells Increases at Multiple Sclerosis Relapse: Sex Differences

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2012; 13(6): 6698-6710 Nº de citas: 18 [doi:10.3390/ijms13066698]

Carbone, J; Sarmiento, E; Del Pozo, N; Rodriguez-Molina, JJ; Navarro, J; Fernandez-Yanez, J; Palomo, J; Villa, A; Munoz, P; Fernandez-Cruz, E.

Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections

CLINICAL TRANSPLANTATION. 2012; 26(3): 277-283 Nº de citas: 22 [doi:10.1111/j.1399-0012.2012.01653.x]

Andres, C; Teijeiro, R; Alonso, B; Sanchez-Madrid, F; Martinez, ML; de Villoria, JG; Fernandez-Cruz, E; Sanchez-Ramon, S.

Long-Term Decrease in VLA-4 Expression and Functional Impairment of Dendritic Cells during Natalizumab Therapy in Patients with Multiple Sclerosis

PLoS One. 2012; 7(4): Nº de citas: 16 [doi:10.1371/journal.pone.0034103]

Estecha, A; Aguilera-Montilla, N; Sanchez-Mateos, P; Puig-Kroger, A.

RUNX3 Regulates Intercellular Adhesion Molecule 3 (ICAM-3) Expression during Macrophage Differentiation and Monocyte Extravasation

PLoS One. 2012; 7(3): Nº de citas: 24 [doi:10.1371/journal.pone.0033313]

Aviles-Izquierdo, JA; Lazaro-Ochaita, P.

Histological ulceration as a prognostic factor in cutaneous melanoma: a study of 423 cases in Spain

CLINICAL & TRANSLATIONAL ONCOLOGY. 2012; 14(3): 237-240 Nº de citas: 10 [doi:10.1007/s12094-012-0790-6]

Pajuelo, L; Calvino, E; Diez, JC; Boyano-Adanez, MD; Gil, J; Sancho, P.

Dequalinium induces apoptosis in peripheral blood mononuclear cells isolated from human chronic lymphocytic leukemia

INVESTIGATIONAL NEW DRUGS. 2011; 29(6): 1156-1163 Nº de citas: 19 [doi:10.1007/s10637-010-9454-y]

Borte, M; Quinti, I; Soresina, A; Fernandez-Cruz, E; Ritchie, B; Schmidt, DS; McCusker, C.

Efficacy and Safety of Subcutaneous VivaglobinA (R) Replacement Therapy in Previously Untreated Patients with Primary Immunodeficiency: A Prospective, Multicenter Study

JOURNAL OF CLINICAL IMMUNOLOGY. 2011; 31(6): 952-961 Nº de citas: 37 [doi:10.1007/s10875-011-9588-5]